Congenital blindness is protective for schizophrenia and other psychotic illness. A whole-population study

Vera A Morgan1, Melanie Clark2, Julie Crewe3

  • 1Neuropsychiatric Epidemiology Research Unit, Division of Psychiatry, Faculty of Health and Medical Sciences, University of Western Australia, Medical Research Foundation Building, Rear 50, Murray Street, Perth 6000, Australia; Centre for Clinical Research in Neuropsychiatry, Division of Psychiatry, Faculty of Health and Medical Sciences, University of Western Australia, Medical Research Foundation Building, Rear 50, Murray Street, Perth 6000, Australia.

Schizophrenia Research
|December 13, 2018
PubMed

Insights

Congenital blindness, particularly cortical blindness, appears protective against schizophrenia and psychotic illness. This large study supports that early vision loss may prevent psychosis development.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Ophthalmology

Background:

  • Previous research suggests a link between congenital blindness and reduced risk of schizophrenia.
  • This study investigates the prevalence of schizophrenia and psychotic illness in individuals with congenital/early blindness using a large population cohort.

Discussion:

  • Cortical blindness, affecting visual processing in the brain, showed a significant protective effect against schizophrenia and psychotic illness.
  • Peripheral blindness, affecting the eye's ability to detect light, did not demonstrate the same protective effect.
  • The findings suggest a specific mechanism related to visual cortex development or function in psychosis prevention.

Key Insights:

  • Congenital/early cortical blindness is strongly associated with a lack of schizophrenia and psychotic illness development.
  • Congenital/early peripheral blindness shows a less pronounced protective effect compared to cortical blindness.
  • The study reinforces the hypothesis that visual pathway integrity plays a role in the pathophysiology of schizophrenia.

Outlook:

  • Further research into the neurobiological mechanisms underlying the protective effect of cortical blindness is warranted.
  • Investigating potential therapeutic targets based on these findings could offer novel approaches to psychosis prevention.
  • Exploring the role of visual processing in other mental health conditions may reveal new insights.

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.9K
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.4K
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
953
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.7K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
599